Guideline: Breast Cancer Radiotherapy (Hungary): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::National Institute of Oncology]]. | '''Sponsor, manager or home institution:''' [[dataOwner::National Institute of Oncology]]. | ||
'''Type of information:''' Latest scientific evidence to provide a comprehensive framework for the treatment of various stages and types of breast cancer. [[availableVariable::medical procedures]], [[availableVariable:: | '''Type of information:''' Latest scientific evidence to provide a comprehensive framework for the treatment of various stages and types of breast cancer. [[availableVariable::medical procedures]], [[availableVariable::tumour staging]]. [https://real.mtak.hu/62459/ Click here to learn more]. | ||
'''Cancer areas of interest:''' [[hasCancerType::C50: Breast cancer]]. [https://real.mtak.hu/62459/ Click here to learn more]. | '''Cancer areas of interest:''' [[hasCancerType::C50: Breast cancer]]. [https://real.mtak.hu/62459/ Click here to learn more]. | ||
'''Access to information:''' [https://real.mtak.hu/62459/ Click here to access]. | '''Access to information:''' [https://real.mtak.hu/62459/ Click here to access]. | ||
Revision as of 15:03, 27 August 2024
Go back to Hungary page
Primary purpose: To update the 2009 radiotherapy guidelines for breast cancer based on new scientific evidence, specifying recommendations for various stages and conditions of the disease.
Sponsor, manager or home institution: National Institute of Oncology.
Type of information: Latest scientific evidence to provide a comprehensive framework for the treatment of various stages and types of breast cancer. medical procedures, tumour staging. Click here to learn more.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
